Published in Folia Haematol Int Mag Klin Morphol Blutforsch on January 01, 1969
Glucose-6-phosphate dehydrogenase deficiency. Lancet (2008) 8.26
Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med (1991) 5.69
Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet (1989) 3.42
Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study. Hepatology (1997) 3.10
Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis. Gut (2002) 1.98
Meta-analysis and review of prospective randomized trials comparing laparoscopic and Lichtenstein techniques in recurrent inguinal hernia repair. Hernia (2014) 1.86
High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda. Hepatology (1998) 1.79
Effect on blood coagulation of massive intravascular haemolysis. Blood (1969) 1.61
Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol (2000) 1.56
Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and premalignant lesions in patients with cirrhosis. Hepatology (2001) 1.53
Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: results of an Italian Prostate Cancer Project study. J Clin Oncol (1999) 1.51
Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology (1992) 1.49
Serum gamma-glutamyl transpeptidase activity in myocardial infarction. Br Heart J (1965) 1.47
Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am J Gastroenterol (2001) 1.47
Normal aminotransferase concentrations in patients with antibodies to hepatitis C virus. BMJ (1994) 1.47
Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism. Hepatology (1991) 1.43
Two point mutations are responsible for G6PD polymorphism in Sardinia. Am J Hum Genet (1989) 1.42
Treatment of primary sclerosing cholangitis with low-dose ursodeoxycholic acid: results of a retrospective Italian multicentre survey. Dig Liver Dis (2003) 1.42
No association between genetic hemochromatosis and alpha1-antitrypsin deficiency. Hepatology (1996) 1.42
Inadequate dietary intake but not renal tubular acidosis is associated with bone demineralization in primary biliary cirrhosis. Aliment Pharmacol Ther (2007) 1.40
The role of the 595-nm pulsed dye laser in treating superficial basal cell carcinoma: outcome of a double-blind randomized placebo-controlled trial. Br J Dermatol (2015) 1.39
[The UV record. Document for quality control, therapy planning and risk assessment in dermatologic photo- and photochemotherapy]. Hautarzt (2000) 1.38
Hepatitis G virus infection in the elderly. Ital J Gastroenterol Hepatol (1998) 1.37
A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases. Ann Oncol (2006) 1.29
Association of thalassaemia intermedia with a beta-globin gene haplotype. Br J Haematol (1987) 1.28
Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol (2001) 1.21
Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis. Hepatology (1997) 1.20
Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgery. Cancer Treat Rev (2008) 1.18
Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study. Gastroenterology (1995) 1.17
Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology (1992) 1.16
A gene controlling fetal hemoglobin expression in adults is not linked to the non-alpha globin cluster. EMBO J (1983) 1.16
Inflammatory pseudotumour of the liver with malignant transformation. Report of two cases. Ital J Gastroenterol (1996) 1.16
Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women. Hum Mol Genet (2000) 1.16
Acute liver and renal failure during treatment with buprenorphine at therapeutic dose. Dig Liver Dis (2008) 1.14
Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study. Gastroenterology (1996) 1.12
Bile acid-induced inhibition of the lymphoproliferative response to phytohemagglutinin and pokeweed mitogen: an in vitro study. Gastroenterology (1980) 1.12
Specific binding sites for H-ferritin on human lymphocytes: modulation during cellular proliferation and potential implication in cell growth control. Blood (1991) 1.11
Oxidative status and malondialdehyde in beta-thalassaemia patients. Eur J Clin Invest (2002) 1.09
High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: evidence for nosocomial transmission of HCV. Kidney Int (1995) 1.09
Hepatocellular carcinoma: comparison between liver transplantation, resective surgery, ethanol injection, and chemoembolization. Transpl Int (1998) 1.09
Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis C. J Hepatol (2001) 1.09
Technological properties of Oenococcus oeni strains isolated from typical southern Italian wines. Lett Appl Microbiol (2010) 1.08
Radiofrequency interstitial thermal ablation of hepatocellular carcinoma in liver cirrhosis. Role of the laparoscopic approach. Surg Endosc (2001) 1.08
Safety and efficacy of laparoscopic radiofrequency ablation of hepatocellular carcinoma in patients with liver cirrhosis. Surg Endosc (2003) 1.07
Prednisone or prednisolone for the treatment of chronic active hepatitis? A comparison of plasma availability. Br J Clin Pharmacol (1978) 1.07
Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers. J Hepatol (1997) 1.07
Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis. Hepatology (1996) 1.06
Liver and biliary problems in cystic fibrosis. Semin Liver Dis (1998) 1.06
Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis. J Pediatr (1990) 1.06
Oral isobutyramide therapy in patients with thalassemia intermedia: results of a phase II open study. Blood Cells Mol Dis (2000) 1.06
Correction of abnormal coagulation in chronic liver disease by combined use of fresh-frozen plasma and prothrombin complex concentrates. Lancet (1976) 1.05
New syndrome manifested by mandibular hypoplasia, acroosteolysis, stiff joints and cutaneous atrophy (mandibuloacral dysplasia) in two unrelated boys. Birth Defects Orig Artic Ser (1971) 1.04
Iron stores, response to alpha-interferon therapy, and effects of iron depletion in chronic hepatitis C. Liver (1996) 1.04
Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C. J Hepatol (1998) 1.03
Feasibility of prenatal diagnosis of beta-thalassaemia with synthetic DNA probes in two Mediterranean populations. Lancet (1985) 1.03
Serum cholesterol and chronic hepatitis C. Ital J Gastroenterol (1997) 1.02
Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration. Hepatology (1991) 1.02
Antibody to carbonic anhydrase II is present in primary biliary cirrhosis (PBC) irrespective of antimitochondrial antibody status. Clin Exp Immunol (1998) 1.02
Gamma-glutamyl transpeptidase: a clinical and experimental study. Digestion (1972) 1.02
The expression of uridine diphosphate glucuronosyltransferase gene is a major determinant of bilirubin level in heterozygous beta-thalassaemia and in glucose-6-phosphate dehydrogenase deficiency. Br J Haematol (1997) 1.02
Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis. Gut (2006) 1.01
Blood fetal microchimerism in primary biliary cirrhosis. Clin Exp Immunol (2000) 1.01
Role of hemichrome binding to erythrocyte membrane in the generation of band-3 alterations in beta-thalassemia intermedia erythrocytes. Blood (1995) 1.01
Non-transferrin-bound iron in myelodysplastic syndromes: a marker of ineffective erythropoiesis? Hematol J (2000) 1.00
Morbidity risk in HFE associated hereditary hemochromatosis C282Y heterozygotes. Toxicology (2002) 1.00
Persistence of circulating HBsAg/IgM complexes in acute viral hepatitis, type B: an early marker of chronic evolution. Lancet (1982) 1.00
Iron overload in porphyria cutanea tarda. Haematologica (1999) 0.99
A novel keratinocyte mitogen: regulation of leptin and its functional receptor in skin repair. J Invest Dermatol (2001) 0.99
Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload. J Rheumatol (1997) 0.99
Tumor necrosis factor alpha promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis. Blood (2001) 0.98
Redox-modulated pathways in inflammatory skin diseases. Free Radic Biol Med (2001) 0.98
Occurrence of biogenic amine-forming lactic acid bacteria in wine and cider. Food Microbiol (2010) 0.98
Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study. Hepatology (1992) 0.98
Coagulation and splenectomy: an overview. Ann N Y Acad Sci (2005) 0.97
Long term response to therapy of chronic anti-HBe-positive hepatitis B is poor independent of type and schedule of interferon. Am J Gastroenterol (1999) 0.97
Controlled trial of streptokinase and heparin in acute myocardial infarction. Lancet (1971) 0.97
Idiopathic haemochromatosis and HLA antigens in Italy: is A3 Bw35 HLA haplotype a marker for idiopathic haemochromatosis gene in north east regions? J Clin Pathol (1986) 0.97
Drug prescriptions in liver and biliary disease: something more to be done. Ital J Gastroenterol Hepatol (1998) 0.97
Genes and (auto)immunity in primary biliary cirrhosis. Genes Immun (2005) 0.96
Interaction between homozygous beta (0) thalassaemia and the Swiss type of hereditary persistence of fetal haemoglobin. Br J Haematol (1981) 0.96
Identification of copper/zinc superoxide dismutase as a nitric oxide-regulated gene in human (HaCaT) keratinocytes: implications for keratinocyte proliferation. Biochem J (2000) 0.95
Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis. Dig Liver Dis (2003) 0.95
Immunohistochemical evidence for a lack of ferritin in duodenal absorptive epithelial cells in idiopathic hemochromatosis. Gastroenterology (1989) 0.95
Is hepatocellular carcinoma in cirrhosis an actual indication for liver transplantation? Transplant Proc (1997) 0.94
Molecular characterization of lactic acid populations associated with wine spoilage. J Basic Microbiol (2004) 0.94
A combination of chenodeoxycholic acid and ursodeoxycholic acid is more effective than either alone in reducing biliary cholesterol saturation. Hepatology (1982) 0.94
Recurrent HCV hepatitis after liver transplantation. Lancet (1993) 0.94
Relationship between TNF-alpha and iron metabolism in differentiating human monocytic THP-1 cells. Br J Haematol (2000) 0.93
Cream psoralen plus ultraviolet A therapy for granuloma annulare. Br J Dermatol (2001) 0.93
Three-month treatment with a long-acting gonadotropin-releasing hormone agonist of patients with benign prostatic hyperplasia: effects on tissue androgen concentration, 5 alpha-reductase activity and androgen receptor content. J Clin Endocrinol Metab (1989) 0.92
Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease. Hepatology (1999) 0.92
Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis. Gut (1996) 0.92
Liver iron concentration in chronic viral hepatitis: a study of 98 patients. Eur J Gastroenterol Hepatol (1995) 0.92
The antioxidant network of the stratum corneum. Curr Probl Dermatol (2001) 0.92
Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis. Hepatology (1994) 0.92